Most leading US publicly traded managed care insurers increased their full-year earnings estimates after reporting second quarter 2026 results. This comes despite facing higher medical costs and shifts in membership, especially within Medicare Advantage plans focused on seniors. The trend of rising medical expenses has continued from 2025 into 2026, impacting insurer operations. However, the positive earnings outlook suggests these companies are managing challenges effectively, which could influence investor confidence going forward.
Morgan Stanley lowered Avis Budget Group's price target from $99 to $95 as the company faces a class-action lawsuit accusing major investor Pentwater Capital Management of manipulating its stock price. The lawsuit claims Pentwater artificially inflat...
Deutsche Bank has reiterated a Buy rating for The Estée Lauder Companies, signaling confidence in the stock despite industry challenges like cautious consumer spending and supply-chain risks. Estée Lauder's focus on innovation, brand building, and di...
The Chief Operating Officer of Gen Digital sold 28,248 shares recently. This insider sale could indicate a personal financial decision or a strategic move, which investors might watch closely for signals about the company's outlook. While such sales ...
Needham analyst Mike Cikos raised the price target for ServiceNow to $155, citing the company's AI products surpassing $1 billion in annual contract value (ACV) and a ninefold increase in customers using its agentic AI products. ServiceNow aims to ex...
Analyst firm Cowen & Co. maintained a Hold rating on Paychex (NASDAQ:PAYX) while raising its price target from $98 to $117, reflecting confidence in the company's strong financial performance. Paychex has seen a 30% stock increase over six months, dr...
